Estrategias de tratamiento: profilaxis, tratamiento empírico, precoz (anticipado) y dirigido de candidiasis invasora en el enfermo crítico no neutropénico

Palacio, Amalia del; Alambra, Almudena; Cuétara, M. Soledad.
Rev. iberoam. micol ; 23(1): 35-38, ene. 2006. tab
Artículo en Es | IBECS (España) | ID: ibc-045002

Documentos relacionados

  1. Clinical considerations in the early treatment of invasive mould infections and disease.
  2. Clinical experience with new formulation SUBA®-itraconazole for prophylaxis in patients undergoing stem cell transplantation or treatment for haematological malignancies.
  3. Echinocandins in the management of invasive fungal infections, Part 2.
  4. Treatment of invasive candidiasis with echinocandins.
  5. Role of FDG PET/CT in monitoring treatment response in patients with invasive fungal infections.
  6. New pharmacological opportunities for the treatment of invasive mould diseases.
  7. Infection and Prophylaxis During Normothermic Liver Perfusion: Audit of Incidence and Pharmacokinetics of Antimicrobial Therapy.
  8. <i>Candida</i> Prophylaxis and Treatment in Critically Ill Patients after Abdominal Surgery: A Survey of Practice.
  9. Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation.
  10. Atypical Candidiasis of the Gnathotheca in a Lesser Flamingo (<i>Phoeniconaias minor</i>).